Amanote Research

Amanote Research

    RegisterSign In

A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3

Neurology - United States
doi 10.1212/wnl.0b013e318278a059
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

November 26, 2012

Authors
B. S. ConnollyL. K. PrashanthB. B. ShahC. MarrasA. E. Lang
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3

Neurology
Neurology
2012English

Spinocerebellar Ataxia Type 3

2020English

Axonal Inclusions in Spinocerebellar Ataxia Type 3

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2010English

Therapeutic Prospects for Spinocerebellar Ataxia Type 2 and 3

Drugs of the Future
Pharmacology
2009English

Spinocerebellar Ataxia Type 13

2020English

Spinocerebellar Ataxia Type 8

2020English

Spinocerebellar Ataxia Type 12

2020English

Spinocerebellar Ataxia Type 37

2020English

Spinocerebellar Ataxia Type 2

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy